First Manhattan’s iShares US Pharmaceuticals ETF IHE Stock Holding History

First Manhattan’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-720	Closed	-$48.9K	–	962
2024 Q1	$48.9K	Hold	720	–	–	﹤0.01%	897
2023 Q4	$44.5K	Hold	720	–	–	﹤0.01%	895
2023 Q3	$42.5K	Hold	720	–	–	﹤0.01%	900
2023 Q2	$43K	Hold	720	–	–	﹤0.01%	911
2023 Q1	$42.1K	Hold	720	–	–	﹤0.01%	943
2022 Q4	$44.7K	Hold	720	–	–	﹤0.01%	964
2022 Q3	$40K	Hold	720	–	–	﹤0.01%	965
2022 Q2	$45K	Hold	720	–	–	﹤0.01%	990
2022 Q1	$46K	Buy	+720	New	+$45.6K	﹤0.01%	1017

Other funds holding IHE

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

MSCM

McElhenny Sheffield Capital Management Dallas, Texas $403M AUM 28.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACA

Aptus Capital Advisors Fairhope, Alabama $12.7B AUM 17.41% 1-Year Est. Return

Rockport Wealth Fairview Park, Ohio $549M AUM 22.95% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

First Manhattan's IHE Position: Q2 2024 in Review

First Manhattan sold out of iShares US Pharmaceuticals ETF (IHE) in Q2 2024, closing a stake of 720 shares — an estimated $48.9K sold.

First Manhattan first reported a position in IHE in Q1 2022 and held it in 9 quarters. The position peaked at $48.9K in Q1 2024. 143 funds tracked by Wall St. Rank hold IHE as of Q2 2024.

First Manhattan reported no remaining iShares US Pharmaceuticals ETF position as of Q2 2024 after selling out during the quarter.
First Manhattan sold 720 iShares US Pharmaceuticals ETF shares in Q2 2024, an estimated $48.9K.
First Manhattan first reported a position in iShares US Pharmaceuticals ETF in Q1 2022 and held it in 9 quarters.
First Manhattan's iShares US Pharmaceuticals ETF position peaked at $48.9K in Q1 2024.
143 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2024.

Based on First Manhattan's 13F filing for Q2 2024, filed 14 Aug 2024.